Latest Immunology Jobs

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

The VP, Medicine Development Leader for Cancer Vaccines will lead the global development of GSK's cancer vaccine, working with cross-functional teams to define the strategic vision and operational plan. Key responsibilities include managing the development team, ensuring regulatory approval, and aligning with GSK's oncology strategy.

GSK £340,500 – £567,500 pa

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

The VP, Medicine Development Leader for Cancer Vaccines will lead the global development of GSK's cancer vaccine, from early stages through approval and launch. This role involves strategic planning, team leadership, and collaboration with various stakeholders across R&D and commercial functions to ensure the successful development and commercialization of the vaccine.

GSK

Director, Clinical Operations Asset Lead

Leads clinical operations strategy across the full asset lifecycle, ensuring high-quality, on-time delivery of clinical studies. Works cross-functionally to shape clinical development plans, manage vendor and resourcing strategies, and maintain inspection readiness. Focuses on patient-centric, efficient study execution within a global, matrixed environment.

GSK

Head, Oncology Clinical Development - ADCs

Lead the clinical development strategy for antibody-drug conjugates (ADCs) across multiple tumor types, from early-phase through registrational trials and market launch. Drive integrated clinical and translational research, represent the asset at key governance forums, and shape portfolio-level decision-making in oncology. Work across global cross-functional teams to advance innovative therapies within a matrixed biopharma environment.

GSK United States £242,250 – £403,750 pa

Director, Clinical Operations Asset Lead

Leads clinical operations strategy and execution across the full lifecycle of a drug development asset, ensuring high-quality, compliant, and efficient delivery of global clinical trials. Works cross-functionally to shape development plans, manage risk, and align operational delivery with scientific and regulatory goals. Provides strategic leadership to study teams and represents clinical operations at senior governance levels.

GSK

Head, Oncology Clinical Development - ADCs

Leads the end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and launch readiness. Responsible for shaping clinical strategy, overseeing global trials, engaging with regulatory authorities, and leading cross-functional teams in a matrixed environment. Involves governance leadership, scientific advisory boards, and integration of innovative approaches such as AI/ML and real-world evidence to accelerate development.

GSK US$242,250 – US$403,750 pa

Head, Oncology Clinical Development - ADCs

Leads the clinical development strategy for antibody-drug conjugates (ADCs) in oncology, spanning early- to late-phase trials across multiple tumor types. Responsible for end-to-end asset development, including regulatory approval and launch readiness, with a focus on scientific rigor, innovation in trial design, and cross-functional collaboration. Engages with global health authorities, governance bodies, and external experts to shape clinical and translational strategies.

GSK US$242,250 – US$403,750 pa

Director, Clinical Operations Asset Lead

Leads clinical operations for a key asset across its full lifecycle, setting the operational strategy and ensuring high-quality, on-time delivery of clinical studies. Works cross-functionally to align study execution with scientific and regulatory goals, driving innovation and efficiency while managing risks and stakeholder engagement. Serves as the primary accountability point for clinical operations within global governance structures.

GSK €119,250 – €198,750 pa

Head, Oncology Clinical Development - ADCs

Leads end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and market launch. Drives integrated clinical strategy, translational research, regulatory submissions, and cross-functional collaboration across global teams. Engages with governance bodies, scientific advisory boards, and external experts to shape development and competitive positioning.

GSK US$242,250 – US$403,750 pa

Director, Clinical Operations Asset Lead

Leads clinical operations for a key asset across its full lifecycle, setting the operational strategy and ensuring high-quality, on-time delivery of clinical studies. Works cross-functionally to align study design with strategic goals, manage vendor and resourcing strategy, and maintain inspection readiness. Serves as the primary escalation point for operational and quality issues, driving governance and risk management.

GSK

Hybrid Permanent

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

This role involves leading the clinical development strategy for GSK's hematology portfolio, from early-phase studies to market launch. Responsibilities include shaping scientific approaches, managing cross-functional teams, and ensuring regulatory compliance. The role requires deep expertise in hematology/oncology and a proven track record in clinical trial design and execution.

GSK United States

Hybrid Permanent

Medical Director, Oncology Clinical Development - Hematology

The Medical Director, Oncology Clinical Development - Hematology is a physician-led role focused on guiding clinical strategy and medical oversight in oncology drug development. This position involves leading medical monitoring, interpreting clinical and safety data, contributing to protocol design, and engaging with investigators and regulatory bodies. The role operates within cross-functional teams to ensure patient safety and clinical integrity across Phase I–III trials in hematology and oncology.

GSK United States

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

This role involves leading the clinical development strategy for GSK's Hematology portfolio, from early-phase studies to market launch. Responsibilities include shaping scientific approaches, managing cross-functional teams, and ensuring regulatory compliance. The role requires extensive experience in oncology clinical development and leadership.

GSK

Medical Director, Oncology Clinical Development - Hematology

This role involves leading medical oversight in oncology clinical development, focusing on hematology. The Medical Director will guide study design, ensure patient safety, interpret clinical data, and collaborate with cross-functional teams and external experts. It emphasizes physician leadership in trials from Phase I–III, with a strong focus on real-world impact and regulatory engagement.

GSK £222,750 – £371,250 pa

Vice President - Oncology Clinical Development, Disease Area Head- Hematology

This role involves leading the clinical development strategy for GSK's Hematology portfolio, from early-phase studies to market launch. Responsibilities include shaping scientific approaches, managing cross-functional teams, and ensuring regulatory compliance. The role emphasizes innovation, collaboration, and patient-centric focus.

GSK